glp-1 colorectal cancer risk study november 2025

glp-1 colorectal cancer risk study november 2025 Could medications help slow progression?⁣ ⁣ A new Cleveland Clinic found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to Frontiers | Reassessing cancer risk

Name: glp-1 colorectal cancer risk study november 2025 Could medications help slow progression?⁣ ⁣ A new Cleveland Clinic found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to Frontiers | Reassessing cancer risk
Brand: gerloff.com
SKU: 83965378852
Price: 29.89 USD
Availability: InStock
Rating: 4.893700000000001 (24 reviews)

SKU: 83965378852

4.9

EUR29.89 EUR52.89

Pay in 4 interest-free payments of $7.47 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 8 - Sep 13

Description

Justin Lehmiller, Senior Research Fellow at the Kinsey Institute and one of the studys authors says

The starting dose is typically 20 units (0.6mg)

Additionally, if you're fasting and then eating too quickly or too much during your eating window, you risk triggering nausea, reflux, or dumping-like symptoms